ABBOTT LABORATORIES (ABT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 5B 10B 15B Q2 '21: 10.2B Q3 '21: 10.9B Q4 '21: 11.5B Q1 '22: 11.9B Q2 '22: 11.3B Q3 '22: 10.4B Q4 '22: 10.1B Q1 '23: 9.7B Q2 '23: 10B Q3 '23: 10.1B Q4 '23: 10.2B Q1 '24: 10B Q2 '24: 10.4B Q3 '24: 10.6B Q4 '24: 11B Q1 '25: 10.4B Q2 '25: 11.1B Q3 '25: 11.4B Q4 '25: 11.5B Q1 '26: 11.2B Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Gross Profit Quarterly

0 1.5B 3B 4.5B Q1 '15: 2.7B Q2 '15: 2.8B Q3 '15: 2.8B Q4 '15: 2.8B Q1 '16: 2.6B Q2 '16: 2.9B Q3 '16: 2.9B Q4 '16: 2.9B Q1 '17: 2.8B Q2 '17: 3.1B Q3 '17: 3.5B Q4 '17: 3.7B Q1 '18: 3.7B Q2 '18: 3.9B Q3 '18: 3.9B Q4 '18: 4.1B Q1 '19: 3.9B Q2 '19: 4.2B Q3 '19: 4.2B Q4 '19: 4.4B Q2 '15 Q1 '16 Q4 '16 Q3 '17 Q2 '18 Q1 '19 Q4 '19

Operating Income Quarterly

0 1B 2B 3B Q2 '21: 1.4B Q3 '21: 2.5B Q4 '21: 2.4B Q1 '22: 2.9B Q2 '22: 2.4B Q3 '22: 1.8B Q4 '22: 1.3B Q1 '23: 1.5B Q2 '23: 1.5B Q3 '23: 1.6B Q4 '23: 1.8B Q1 '24: 1.4B Q2 '24: 1.7B Q3 '24: 1.9B Q4 '24: 1.9B Q1 '25: 1.7B Q2 '25: 2.1B Q3 '25: 2.1B Q4 '25: 2.3B Q1 '26: 1.3B Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Net Income Quarterly

0 3.5B 7B 10.5B Q2 '21: 1.2B Q3 '21: 2.1B Q4 '21: 2B Q1 '22: 2.4B Q2 '22: 2B Q3 '22: 1.4B Q4 '22: 1B Q1 '23: 1.3B Q2 '23: 1.4B Q3 '23: 1.4B Q4 '23: 1.6B Q1 '24: 1.2B Q2 '24: 1.3B Q3 '24: 1.6B Q4 '24: 9.2B Q1 '25: 1.3B Q2 '25: 1.8B Q3 '25: 1.6B Q4 '25: 1.8B Q1 '26: 1.1B Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Cost of Revenue Quarterly

0 2B 4B 6B Q2 '21: 4.9B Q3 '21: 4.4B Q4 '21: 4.8B Q1 '22: 5B Q2 '22: 4.9B Q3 '22: 4.6B Q4 '22: 4.6B Q1 '23: 4.3B Q2 '23: 4.5B Q3 '23: 4.6B Q4 '23: 4.6B Q1 '24: 4.5B Q2 '24: 4.6B Q3 '24: 4.7B Q4 '24: 4.9B Q1 '25: 4.5B Q2 '25: 4.9B Q3 '25: 5.1B Q4 '25: 4.9B Q1 '26: 4.9B Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating Cash Flow Quarterly

0 1.5B 3B 4.5B Q2 '21: 2.1B Q3 '21: 2.7B Q4 '21: 3.1B Q1 '22: 2.1B Q2 '22: 2.4B Q3 '22: 2.8B Q4 '22: 2.3B Q1 '23: 1.1B Q2 '23: 1.2B Q3 '23: 1.9B Q4 '23: 3B Q1 '24: 1B Q2 '24: 2B Q3 '24: 2.7B Q4 '24: 2.9B Q1 '25: 1.4B Q2 '25: 2B Q3 '25: 2.8B Q4 '25: 3.3B Q1 '26: 1.3B Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Free Cash Flow Quarterly

0 900M 1.8B 2.7B Q2 '21: 1.7B Q3 '21: 2.2B Q4 '21: 2.5B Q1 '22: 1.7B Q2 '22: 2B Q3 '22: 2.3B Q4 '22: 1.7B Q1 '23: 763M Q2 '23: 696M Q3 '23: 1.3B Q4 '23: 2.3B Q1 '24: 627M Q2 '24: 1.4B Q3 '24: 2.1B Q4 '24: 2.1B Q1 '25: 933M Q2 '25: 1.5B Q3 '25: 2.3B Q4 '25: 2.6B Q1 '26: 916M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 700M 1.4B 2.1B Q3 '19: 1.8B Q1 '20: 1.8B Q2 '20: 1.8B Q3 '20: 1.8B Q1 '21: 1.8B Q2 '21: 1.8B Q3 '21: 1.8B Q1 '22: 1.8B Q2 '22: 1.8B Q3 '22: 1.8B Q1 '23: 1.8B Q2 '23: 1.8B Q3 '23: 1.7B Q1 '24: 1.7B Q2 '24: 1.8B Q3 '24: 1.7B Q1 '25: 1.7B Q2 '25: 1.8B Q3 '25: 1.7B Q1 '26: 1.7B Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 3.00 6.00 9.00 Q2 '21: 3.55 Q3 '21: 4.03 Q4 '21: 3.94 Q1 '22: 4.31 Q2 '22: 4.79 Q3 '22: 4.43 Q4 '22: 3.91 Q1 '23: 3.29 Q2 '23: 2.93 Q3 '23: 2.94 Q4 '23: 3.26 Q1 '24: 3.21 Q2 '24: 3.17 Q3 '24: 3.29 Q4 '24: 7.64 Q1 '25: 7.70 Q2 '25: 7.97 Q3 '25: 7.97 Q4 '25: 3.73 Q1 '26: 3.58 Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.